# FDA Inspection 1211294 - Nageshwara Arvind Dasari, MD - July 20, 2023

Source: https://www.keypedia.com/records/fda_inspections/nageshwara-arvind-dasari-md/1b07b4ba-9b49-40ac-aa87-d6645ef4c377
Source feed: FDA_Inspections

> FDA Inspection 1211294 for Nageshwara Arvind Dasari, MD on July 20, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1211294
- Company Name: Nageshwara Arvind Dasari, MD
- Inspection Date: 2023-07-20
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 902499 - 2014-11-07](https://www.keypedia.com/records/fda_inspections/nageshwara-arvind-dasari-md/22448d84-c244-4f83-b97a-1283ecf96bc5)

Company: https://www.keypedia.com/companies/nageshwara-arvind-dasari-md/b9249dc2-86ad-4a4f-9f8b-d1524bac7871

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c